Immunotherapy, in which cells from the human immune system are unleashed to fight disease, has been the big story in cancer treatment over the past few years. When it works, it can spur long-lasting remission in patients for whom other treatments have failed. But most patients don’t benefit, and there is still no good way to predict who will respond.
A team of researchers led by an engineer from the University of Houston is trying another tack–designing immune system cells that can survive within a tumor even when the nutrients needed to sustain them aren’t available. That should allow the cells to work more efficiently in more people.
Navin Varadarajan, associate professor of chemical and biomolecular engineering at UH, works with T cells, immune cells that can recognize and attack disease cells. But all cells need nutrients to survive, and tumors harbor areas of nutrient limited zones, meaning T cells often die before completing their task, Varadarajan said.
“We know once they get to the tumor, nutrients are limited,” he said. “If they are not able to cope and compete effectively for these nutrients, they’re going to die. The question is, can you engineer the T cells to survive and persist?”
To further the work, Varadarajan has received a $375,000, three-year grant from the Melanoma Research Alliance, part of $8.5 million in new funding awarded to researchers at 28 institutions in six countries.
“These awards will further our ability to improve melanoma outcomes, support the next generation of melanoma researchers and help draw us ever closer to a cure,” said Debra Black, chair and co-founder of the Melanoma Research Alliance.
Varadarajan’s work will use a novel research platform he developed to allow researchers to study T cells at a single-cell level, as well as single cell T cell-tumor cell interactions. The proprietary chip-based platform works by co-incubating T cells and tumor cells in dense arrays of nanoliter wells, or nanowells, and monitoring the functional interaction between the cells. The goal is to engineer T cells that retain their anti-cancer properties in the inhospitable environment of a tumor.
The platform will allow researchers to track thousands of interactions and hone in on the traits that predict success. The engineered T cells will then be tested in mice at the University of Texas MD Anderson Cancer Center. This work builds on existing research conducted by Melisa Martinez, a postdoctoral researcher in Varadarajan’s lab, in collaboration with an MD Anderson team headed by Chantale Bernatchez.
Varadarajan began working on immunotherapy after arriving at UH about seven years ago. Since then, the therapy has taken off.
“It’s amazing how well it’s done,” he said. “It’s become a major player in clinical oncology. All of our work now is going toward getting it to work for more people.”
He said the treatment is effective for about 20 percent of patients who receive it.
“For now, we don’t have good biomarkers to tell who is a good candidate for immunotherapy,” he said. Engineering T cells to work more broadly could be another way to increase the therapy’s effectiveness. “It’s a complementary approach.”
RT @BCMEthics: Alternative science: The importance of informed policymaking https://t.co/O3lLsZAsr3 via @bcmhouston
Here?s a tip: Indented cement shows unique properties. https://t.co/GuxKPV2NgV https://t.co/XBSiKhJ5IG
Congratulations to Drs. Jonathan Davies, James Orengo and Geoffrey Preidis, recipients of the 2017 Chao Physician-S? https://t.co/8OZYgv4laf
@BCMEthics' Cody Brannan says peer-reviewed data should be considered for science-based policymaking. https://t.co/nkLOkMfQ7h
Baylor College of MedicineBaylorCollegeOfMedicine
Baylor College of Medicine Center for Medical Ethics and Health Policy's Cody Brannan says peer-reviewed data and scientific consensus should be considered fo...
@RandyPro Congratulations, Randy! Best wishes to you.
CHI St Luke's Health@CHI_StLukes
RT @CHI_Updates: Even hours after a near-drowning incident, mild symptoms can cause serious complications - learn more with this info from?
Tips for enjoying a healthy #barbecue: https://t.co/p4NKLod53I @FocusedonHealth #endcancer https://t.co/iaP5EstrZP
RT @UTSDhouston: I scream! You scream! We all scream for ice cream! Dean Valenza's 9th Annual Scream Out ice? https://t.co/kzog82SPID
"This doctor, who I didn't know at the time, was going to change our lives." Read full story: https://t.co/3Kn1q4rap6 #texaschildrens
Magic Valley groups ride to honor Vietnam Veterans https://t.co/Bc1PCvQYfH via @emilydukeKMVT
Communities of cells communicate to coordinate their actions, but how do they coordinate with other communities?? https://t.co/TynLuAsTS6
#Trampolines are responsible for thousands of annual ER visits. Dr. Sasha Adams shared safety tips w/ @Fox26Houston: https://t.co/4sbo09Lc1j
After 3-year-old Ishaan fell into a pool and nearly drowned, he was fortunate to be in the care of Dr. Soham Roy: https://t.co/rCkS06zkUs
MD Anderson Cancer CenterMDAnderson
“I wasn’t going to give up. If there’s any chance, I’m going to take it,” Maria Newhouse recalls telling herself when she was diagnosed with breast cancer. Lea...